HEATHER MATTHEWS: Open Payments
NPI 1477538098 · KINSTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,158 in 62 payments from 17 companies in 2025. Trend: 2023 $1,250 · 2024 $1,646 · 2025 $1,158
Food & beverage: $1,158
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $206 |
| AstraZeneca Pharmaceuticals LP | 6 | $185 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $179 |
| GlaxoSmithKline, LLC. | 11 | $178 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Lilly USA, LLC | 4 | $63 |
| ABBVIE INC. | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $48 |
| Exact Sciences Corporation | 2 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
Products named: Kerendia, TRELEGY ELLIPTA, FARXIGA, Ozempic, REXULTI, MOUNJARO, BREZTRI, JARDIANCE.
Industry payments across NC — which companies pay providers there.
